Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells - PubMed (original) (raw)
Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells
R Newton et al. Eur J Biochem. 1998.
Free article
Abstract
The production of inflammatory mediators by epithelial cells in inflammatory lung diseases may represent an important target for the anti-inflammatory effects of glucocorticoids. Nuclear factor-kappaB (NF-kappaB) is a major activator of inflammatory genes and has been proposed as a target for inhibition by glucocorticoids. We have used human pulmonary type-II A549 and airway epithelial BEAS-2B cells to investigate the effect of glucocorticoids on NF-kappaB regulation and kappaB-dependent transcription. In A549 cells following interleukin-1beta (IL-1beta) treatment, there was no effect of dexamethasone on the disappearance of I kappaB alpha protein, its subsequent reappearance 90-min later or the rapid induction of I kappaB alpha mRNA and transcription rate. Expression of p65 and p50/p105 proteins were also unaffected by dexamethasone. In addition, the rapid IL-1beta-induction of NF-kappaB DNA binding and p65 nuclear localisation was unaffected by short (1-6 hours) dexamethasone pre-treatments. Similarly, BEAS-2B cells showed no effect of dexamethasone on IL-1beta-induced NF-kappaB (p50/p65). Stable transfection of a kappaB-dependent reporter in A549 cells resulted in an 8-9-fold activation by IL-1beta or phorbol ester, that was repressed 30-40% by dexamethasone. However, in these cells, IL-1beta induction of inducible nitric oxide synthase, granulocyte-macrophage colony stimulating factor and cyclooxygenase-2 mRNA showed 70-90% repression by dexamethsone. We, therefore, conclude that in these epithelial cells, the repressive effects of glucocorticoids are not mediated by up-regulation of I kappaB alpha, decreased p50/p65 gene expression or inhibition of NF-kappaB DNA binding. Furthermore, since the maximal repression of IL-1beta or phorbol-ester-induced kappaB-dependent transcription by dexamethasone was less than 40%, simple inhibition of kappaB-dependent transcription cannot by itself account for the full repressive effects of glucocorticoids observed in these cells.
Similar articles
- A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids.
Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. Wissink S, et al. Mol Endocrinol. 1998 Mar;12(3):355-63. doi: 10.1210/mend.12.3.0081. Mol Endocrinol. 1998. PMID: 9514153 - Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.
Bonizzi G, Piette J, Merville MP, Bours V. Bonizzi G, et al. Biochem Pharmacol. 2000 Jan 1;59(1):7-11. doi: 10.1016/s0006-2952(99)00290-7. Biochem Pharmacol. 2000. PMID: 10605929 Review. - Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB.
Krakauer T. Krakauer T. Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):317-24. doi: 10.2174/1568010043343714. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15379601 Review.
Cited by
- Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.
King EM, Chivers JE, Rider CF, Minnich A, Giembycz MA, Newton R. King EM, et al. PLoS One. 2013;8(1):e53936. doi: 10.1371/journal.pone.0053936. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23349769 Free PMC article. - Heterogeneity of glucocorticoid resistance in patients with bronchial asthma.
Matsumura Y. Matsumura Y. Int J Biomed Sci. 2010 Sep;6(3):158-66. Int J Biomed Sci. 2010. PMID: 23675190 Free PMC article. - Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomerular endothelial cells upstream of caspase 3 activation.
Messmer UK, Winkel G, Briner VA, Pfeilschifter J. Messmer UK, et al. Br J Pharmacol. 1999 Aug;127(7):1633-40. doi: 10.1038/sj.bjp.0702726. Br J Pharmacol. 1999. PMID: 10455320 Free PMC article. - Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.
Salem S, Harris T, Mok JS, Li MY, Keenan CR, Schuliga MJ, Stewart AG. Salem S, et al. Br J Pharmacol. 2012 Aug;166(7):2036-48. doi: 10.1111/j.1476-5381.2012.01885.x. Br J Pharmacol. 2012. PMID: 22300324 Free PMC article. - Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling.
Franks AL, Berry KJ, DeFranco DB. Franks AL, et al. J Neuroendocrinol. 2020 Jan;32(1):e12786. doi: 10.1111/jne.12786. Epub 2019 Oct 2. J Neuroendocrinol. 2020. PMID: 31469457 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials